Intra-Cellular Therapies, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
AQST
Aquestive Therapeutics, Inc. |
$3.42 | $339.20 M | -5.89 | 142 |
COLL
Collegium Pharmaceutical, Inc. |
$29.18 | $936.95 M | 23.89 | 357 |
EGRX
Eagle Pharmaceuticals, Inc. |
$2.20 | $19.44 M | 1.76 | 134 |
IRWD
Ironwood Pharmaceuticals, Inc. |
$0.62 | $101.80 M | -3.31 | 253 |
ANIP
ANI Pharmaceuticals, Inc. |
$62.56 | $1.35 B | -53.03 | 897 |
DCPH
Deciphera Pharmaceuticals, Inc. |
$25.59 | $2.21 B | -11.58 | 355 |
NBIX
Neurocrine Biosciences, Inc. |
$124.39 | $12.31 B | 42.18 | 1800 |
DVAX
Dynavax Technologies Corporation |
$10.27 | $1.23 B | -20.52 | 405 |
PCRX
Pacira BioSciences, Inc. |
$24.24 | $1.12 B | -10.83 | 788 |
ALKS
Alkermes plc |
$29.83 | $4.92 B | 14.2 | 1800 |
AMPH
Amphastar Pharmaceuticals, Inc. |
$25.82 | $1.22 B | 9.36 | 2028 |
CYTH
Cyclo Therapeutics, Inc. |
$0.72 | $23.59 M | -0.8 | 8 |
AMRX
Amneal Pharmaceuticals, Inc. |
$7.75 | $3.61 B | -194 | 8300 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
